Allopurinol in Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 162 participants.
Also called NCT03745729
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 162 participants
- Registry
-
NCT03745729
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03745729. Randomized; double masking; primary purpose treatment. Start 2019-03-01 (actual); primary completion 2022-07-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Allopurinol in Acute Coronary Syndrome
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- allopurinol sustained-release capsules
- Intervention (Drug)
- placebo capsules
- Lead sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Record details
- Record id
cardio:ct-nct03745729- Content hash
48e6099b9a32100d39b2f948a6023fbcf3bb5c5b4054b2f6dee82913ddbd864b